These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6237132)

  • 1. T cell subset heterogeneity in a series of patients with mycosis fungoides and Sézary syndrome.
    Piepkorn M; Marty J; Kjeldsberg CR
    J Am Acad Dermatol; 1984 Sep; 11(3):427-32. PubMed ID: 6237132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.
    Hofman FM; Meyer PR; Yanagihara E; Modlin RL; Rea TH; Parker JW; Lukes RJ; Taylor CR
    Am J Dermatopathol; 1983 Apr; 5(2):135-43. PubMed ID: 6224436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T cell subsets and nuclear contour index of skin-infiltrating T cells in mycosis fungoides and Sézary syndrome].
    Iwahara K
    Nihon Hifuka Gakkai Zasshi; 1984 Nov; 94(13):1499-507. PubMed ID: 6335535
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K; Löning T; Rehpenning W
    Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes.
    Piepkorn M; Tigelaar RE
    J Invest Dermatol; 1984 Oct; 83(4):281-5. PubMed ID: 6237158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycosis fungoides/Sezary's syndrome progressing to immunoblastic sarcoma. A T-cell lymphoproliferation with both helper and suppressor phenotypes.
    Yanagihara ET; Parker JW; Meyer PR; Cain MJ; Hofman F; Lukes RJ
    Am J Clin Pathol; 1984 Feb; 81(2):249-57. PubMed ID: 6230003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant cutaneous infiltration by OKT6- and OKT8-positive cells in a case of Sézary syndrome.
    Meissner K; Löning T; Heckmayr M; Zschaber R; Jänner M
    Arch Dermatol Res; 1983; 275(3):168-74. PubMed ID: 6351762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
    Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
    Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectron microscopy related to T-cell monoclonal surface antigen in mycosis fungoides.
    Hashimoto K; Iwahara K
    Am J Dermatopathol; 1983 Apr; 5(2):129-34. PubMed ID: 6224435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking mycosis fungoides/Sézary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course.
    Foo SH; Shah F; Chaganti S; Stevens A; Scarisbrick JJ
    Br J Dermatol; 2016 Apr; 174(4):901-4. PubMed ID: 26479768
    [No Abstract]   [Full Text] [Related]  

  • 15. New techniques in the evaluation of cutaneous T-cell lymphoma.
    van Vloten WA; Willemze R
    Dermatol Clin; 1985 Oct; 3(4):665-72. PubMed ID: 3916173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.
    Glusac EJ; Shapiro PE; McNiff JM
    Dermatol Clin; 1999 Jul; 17(3):601-14, ix. PubMed ID: 10410861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult T-cell leukemia/lymphoma clinically confused with viral/drug skin eruptions and pathologically misinterpreted as mycosis fungoides/Sézary syndrome.
    AbdullGaffar B; Abdulrahman S
    J Cutan Pathol; 2021 Sep; 48(9):1103-1108. PubMed ID: 33354782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Sézary cells. A new preparatory method for their identification and enumeration.
    Fletcher V; Zackheim HS; Beckstead JH
    Arch Pathol Lab Med; 1984 Dec; 108(12):954-8. PubMed ID: 6239604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.